| For: | Wu CS, Lee TY, Chao HW. Targeting glypican-3 as a new frontier in liver cancer therapy. World J Hepatol 2025; 17(9): 107671 [PMID: 41024885 DOI: 10.4254/wjh.v17.i9.107671] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v17/i9/107671.htm |
| Number | Citing Articles |
| 1 |
Didem Agac Cobanoglu, Samantha Franklin, Yue Hu, Devon J. Boland, Xiaotong Song. CAR Intrinsic Design Pre-Shapes Transcriptional and Metabolic Networks in CAR T Cells. Metabolites 2026; 16(1) doi: 10.3390/metabo16010052
|
| 2 |
Na Li, Shurong Li, Peng Cao, Mengfan Tang, Junfeng Zhang, Wei Zhang, Jinfeng Liu, Chunping Ye, Dan Wu, Xixi Li, Li Dai, Xianglin Zuo. Glypican-3-targeted therapy in hepatocellular carcinoma: biological insights and therapeutic strategies. Cancer Gene Therapy 2026; doi: 10.1038/s41417-026-01058-z
|
| 3 |
Ming-Tze Yang, Jiunn-Min Wang, Chen-Shiou Wu, Shou-Wu Lee, Hsin-Ju Tsai, Chia-Chang Chen, Ying-Cheng Lin, Hui-Fen Liu, Teng-Yu Lee. Serum Outperforms Plasma for Glypican-3 Quantification in Hepatocellular Carcinoma—A Prospective Comparative Study. Journal of Clinical Medicine 2026; 15(2) doi: 10.3390/jcm15020448
|
| 4 |
Faris Alrumaihi, Reem A. Alromaihi, Vikalp Kumar, Shehwaz Anwar. Cancer Vaccines: Molecular Mechanisms, Clinical Progress, and Combination Immunotherapies with a Focus on Hepatocellular Carcinoma. Current Issues in Molecular Biology 2025; 47(12) doi: 10.3390/cimb47121056
|
| 5 |
Muhamad Shafi Kooniyil, Pranav Thomas Alex, Muthuganesh Muthuvel, Alok Srivastava, Sunil Martin. Redesigning CAR therapy to tackle immune effector cell-associated hematotoxicity. Annals of Hematology 2026; 105(5) doi: 10.1007/s00277-026-06982-6
|
| 6 |
Ye-Qin Li, Yuan Liao, Wen Zhang, Guo-Wu Rao, Quan Zheng. Research progress of drugs targeting GPC3 in cancer therapy. Bioorganic Chemistry 2026; 169 doi: 10.1016/j.bioorg.2025.109383
|
| 7 |
Sina Nabiyi, Mohammad Heiat, Ehsan Rezaei. Combination therapy strategies targeting glypican-3 in hepatocellular carcinoma: A comprehensive review. Cytokine & Growth Factor Reviews 2026; 87 doi: 10.1016/j.cytogfr.2025.12.006
|